Schroder Investment Management Group
ITCI

Schroder Investment Management Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-743,230
Closed -$62M 1273
2024
Q4
$62M Sell
743,230
-180,941
-20% -$15.1M 0.06% 257
2024
Q3
$67.7M Buy
924,171
+172,281
+23% +$12.6M 0.07% 231
2024
Q2
$51.5M Buy
751,890
+133,502
+22% +$9.14M 0.06% 276
2024
Q1
$42.8M Sell
618,388
-161,435
-21% -$11.2M 0.05% 325
2023
Q4
$55.9M Buy
779,823
+209,331
+37% +$15M 0.07% 253
2023
Q3
$29.7M Sell
570,492
-149,419
-21% -$7.78M 0.04% 366
2023
Q2
$45.6M Sell
719,911
-226,074
-24% -$14.3M 0.07% 298
2023
Q1
$51.2M Buy
945,985
+82,024
+9% +$4.44M 0.08% 264
2022
Q4
$45.7M Sell
863,961
-13,576
-2% -$718K 0.07% 281
2022
Q3
$40.8M Buy
877,537
+37,021
+4% +$1.72M 0.07% 289
2022
Q2
$49M Sell
840,516
-143,397
-15% -$8.36M 0.07% 261
2022
Q1
$59.4M Sell
983,913
-195,926
-17% -$11.8M 0.08% 248
2021
Q4
$61.8M Buy
1,179,839
+30,498
+3% +$1.6M 0.08% 249
2021
Q3
$42.8M Sell
1,149,341
-155,849
-12% -$5.81M 0.07% 309
2021
Q2
$53.3M Sell
1,305,190
-17,806
-1% -$727K 0.07% 294
2021
Q1
$44.9M Buy
1,322,996
+9,970
+0.8% +$338K 0.06% 328
2020
Q4
$41.8M Buy
1,313,026
+313,129
+31% +$9.96M 0.06% 309
2020
Q3
$23.8M Sell
999,897
-119,645
-11% -$2.85M 0.04% 390
2020
Q2
$28.7M Buy
1,119,542
+1,709
+0.2% +$43.9K 0.05% 338
2020
Q1
$17.3M Buy
1,117,833
+364,938
+48% +$5.65M 0.04% 403
2019
Q4
$25.8M Sell
752,895
-675,656
-47% -$23.2M 0.04% 433
2019
Q3
$10.7M Sell
1,428,551
-1,918
-0.1% -$14.4K 0.02% 604
2019
Q2
$18.6M Buy
1,430,469
+75,757
+6% +$983K 0.03% 461
2019
Q1
$16.5M Buy
1,354,712
+197,356
+17% +$2.4M 0.03% 498
2018
Q4
$13.2K Sell
1,157,356
-43,550
-4% -$496 0.02% 512
2018
Q3
$26.1M Buy
1,200,906
+7,312
+0.6% +$159K 0.04% 433
2018
Q2
$21.2M Buy
+1,193,594
New +$21.2M 0.04% 446